Abstract
Cancer gene therapy is considered a very viable approach for the treatment of cancer. The basic idea is to introduce the therapeutic gene, often in the form of a foreign cDNA, into the cancer or other appropriate target cells. For gene delivery purposes, several viral and non-viral vectors have been described. One vector that has become very popular for the purpose of cancer gene therapy is adenovirus. Main reasons are that the recombinant adenoviruses expressing the foreign therapeutic genes can be easily generated, and that the infection of the target cells with the recombinant adenoviruses produces large quantities of the therapeutic proteins. The review describes the basic characteristics and the molecular biology of adenoviruses. This review further describes various methods to generate the recombinant adenoviruses. These include the methods to generate the first generation adenoviruses (E1 deleted), up to the most recently used gutless viruses (with complete viral deletions). A critical compari son of the advantages and disadvantages of various methods is also described. The review also describes the use of adenoviruses which selectively replicate in cancer cells. The review further describes the various approaches for cancer gene therapy currently being exploited. These include the gene replacement strategies using tumor suppressor genes, anti-oncogenes, use of suicide genes, immunomodulation and anti-angiogenesis approaches. An in depth analysis of the pre-clinical data obtained using adenoviral vectors for these cancer gene therapy approaches is also described. The review concludes with a critical discussion of the adenoviruses for cancer gene therapy.
Keywords: adenovirus, adenoviral vector, cancer gene therapy, foreign cdna, viral vector
Current Genomics
Title: Adenoviral Vectors for Cancer Gene Therapy
Volume: 3 Issue: 3
Author(s): Wenli Zhao, Masanobu Kobayashi, Masuo Hosokawa and Prem Seth
Affiliation:
Keywords: adenovirus, adenoviral vector, cancer gene therapy, foreign cdna, viral vector
Abstract: Cancer gene therapy is considered a very viable approach for the treatment of cancer. The basic idea is to introduce the therapeutic gene, often in the form of a foreign cDNA, into the cancer or other appropriate target cells. For gene delivery purposes, several viral and non-viral vectors have been described. One vector that has become very popular for the purpose of cancer gene therapy is adenovirus. Main reasons are that the recombinant adenoviruses expressing the foreign therapeutic genes can be easily generated, and that the infection of the target cells with the recombinant adenoviruses produces large quantities of the therapeutic proteins. The review describes the basic characteristics and the molecular biology of adenoviruses. This review further describes various methods to generate the recombinant adenoviruses. These include the methods to generate the first generation adenoviruses (E1 deleted), up to the most recently used gutless viruses (with complete viral deletions). A critical compari son of the advantages and disadvantages of various methods is also described. The review also describes the use of adenoviruses which selectively replicate in cancer cells. The review further describes the various approaches for cancer gene therapy currently being exploited. These include the gene replacement strategies using tumor suppressor genes, anti-oncogenes, use of suicide genes, immunomodulation and anti-angiogenesis approaches. An in depth analysis of the pre-clinical data obtained using adenoviral vectors for these cancer gene therapy approaches is also described. The review concludes with a critical discussion of the adenoviruses for cancer gene therapy.
Export Options
About this article
Cite this article as:
Zhao Wenli, Kobayashi Masanobu, Hosokawa Masuo and Seth Prem, Adenoviral Vectors for Cancer Gene Therapy, Current Genomics 2002; 3 (3) . https://dx.doi.org/10.2174/1389202023350516
DOI https://dx.doi.org/10.2174/1389202023350516 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Involvement of ERCC2/XPD and ERCC6/CSB Wild Type Alleles in Protection Against Aging and Cancer
Current Aging Science Postoperative Radiotherapy After Radical Prostatectomy: Adjuvant or Salvage?
Current Cancer Therapy Reviews Proteomics in Computer-Aided Drug Design
Current Computer-Aided Drug Design Herpes Simplex Virus Vectors for Gene Delivery to a Variety of Different Cell Types
Current Gene Therapy Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Current Pharmaceutical Design Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy Applications of Nanosystems to Anticancer Drug Therapy (Part II. Dendrimers, Micelles, Lipid-based Nanosystems)
Recent Patents on Anti-Cancer Drug Discovery Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression
Anti-Cancer Agents in Medicinal Chemistry Efficacy and Cardiovascular Safety of Antidiabetic Medications
Current Drug Safety Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective
Central Nervous System Agents in Medicinal Chemistry Editorial [Clinical Applications of Advanced CT, MRI and Optical Imagings as Well as Spect]
Current Medical Imaging Natural Molecules as Talented Inhibitors of Nucleotide Pyrophosphatases/ Phosphodiesterases (PDEs)
Current Topics in Medicinal Chemistry Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior
Current Drug Delivery Bioinorganic Chemistry: The Study of the Fate of Platinum-Based Antitumour Drugs
Current Chemical Biology Intestinal Immunomodulation. Role of Regulative Peptides and Promising Pharmacological Activities
Current Pharmaceutical Design Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) Organ Preservation by the Association of Chemotherapy and Radiotherapy in Invasive Bladder Cancer
Current Drug Therapy DYRK1A Kinase Inhibitors with Emphasis on Cancer
Mini-Reviews in Medicinal Chemistry The ALK Gene, An Attractive Target for Inhibitor Development
Current Topics in Medicinal Chemistry